Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Cullinan Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +1 vs. Q4 2023
- Shares held
- 39.4M
- +2.54M (+6.9%) vs. Q4 2023
- Total value
- $670.8M
- +$295.5M (+78.7%) vs. Q4 2023
- New holders
- 19
- 41 more added
- Sold out
- 18
- 37 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Oncology Impact Management LP | 7,648,268 | $130.3M | 20.95% | 00.0% | Unchanged |
| BVF Inc | 3,196,701 | $54.5M | 1.50% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 2,924,842 | $49.8M | 9.96% | −495,000−14.5% | Reduced |
| Franklin Resources Inc | 2,696,762 | $46.0M | 0.01% | −584,518−17.8% | Reduced |
| BlackRock Inc. | 2,428,993 | $41.4M | 0.00% | −33,281−1.4% | Reduced |
| Vanguard Group Inc | 1,774,345 | $30.2M | 0.00% | +2,902+0.2% | Added |
| State Street Corp | 1,425,459 | $24.3M | 0.00% | +860,055+152.1% | Added |
| Paradigm Biocapital Advisors LP | 1,348,015 | $23.0M | 0.81% | +1,348,015 | New |
| Braidwell LP | 1,240,865 | $21.1M | 0.68% | 00.0% | Unchanged |
| Nextech Invest AG | 1,221,145 | $20.8M | 3.30% | 00.0% | Unchanged |
| Morgan Stanley | 1,152,644 | $19.6M | 0.00% | +232,745+25.3% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,138,531 | $19.4M | 0.34% | +1,138,531 | New |
| Citadel Advisors LLC | 1,109,171 | $18.9M | 0.02% | −23,718−2.1% | Reduced |
| Dimensional Fund Advisors LP | 993,377 | $16.9M | 0.00% | +77,619+8.5% | Added |
| Adage Capital Partners GP, L.L.C. | 950,000 | $16.2M | 0.03% | +950,000 | New |
| Logos Global Management LP | 700,000 | $11.9M | 1.26% | +700,000 | New |
| Geode Capital Management, LLC | 677,330 | $11.5M | 0.00% | +21,666+3.3% | Added |
| Rubric Capital Management LP | 626,929 | $10.7M | 0.32% | 00.0% | Unchanged |
| Tang Capital Management LLC | 571,138 | $9.73M | 1.01% | −200,000−25.9% | Reduced |
| Deutsche Bank AG | 549,276 | $9.36M | 0.00% | +3,692+0.7% | Added |
| OrbiMed Advisors LLC | 517,606 | $8.82M | 0.17% | −27,242−5.0% | Reduced |
| Ameriprise Financial Inc | 420,217 | $7.16M | 0.00% | +365,296+665.1% | Added |
| Renaissance Technologies LLC | 321,100 | $5.47M | 0.01% | +57,012+21.6% | Added |
| Northern Trust Corp | 263,949 | $4.50M | 0.00% | −2,973−1.1% | Reduced |
| Affinity Asset Advisors, LLC | 258,588 | $4.41M | 0.72% | −41,412−13.8% | Reduced |
| Charles Schwab Investment Management Inc | 257,873 | $4.39M | 0.00% | +11,168+4.5% | Added |
| PFM Health Sciences, LP | 255,967 | $4.36M | 0.22% | +255,967 | New |
| Parkman Healthcare Partners LLC | 178,396 | $3.04M | 0.37% | −351,481−66.3% | Reduced |
| Goldman Sachs Group Inc | 169,367 | $2.89M | 0.00% | +41,052+32.0% | Added |
| UBS Group AG | 166,740 | $2.84M | 0.00% | +25,961+18.4% | Added |
| Bank of America Corp | 131,349 | $2.24M | 0.00% | −4,063−3.0% | Reduced |
| Qube Research & Technologies Ltd | 115,112 | $1.96M | 0.00% | +108,266+1,581.4% | Added |
| Rafferty Asset Management, LLC | 97,055 | $1.65M | 0.01% | +97,055 | New |
| First Trust Advisors LP | 95,771 | $1.63M | 0.00% | +2,896+3.1% | Added |
| Bank of New York Mellon Corp | 94,240 | $1.61M | 0.00% | −4,763−4.8% | Reduced |
| Nuveen Asset Management, LLC | 93,222 | $1.59M | 0.00% | +4,899+5.5% | Added |
| Citigroup Inc | 85,574 | $1.46M | 0.00% | +75,004+709.6% | Added |
| Kennedy Capital Management, Inc. | 84,234 | $1.44M | 0.03% | −75,778−47.4% | Reduced |
| Algert Global LLC | 79,680 | $1.36M | 0.05% | +38,660+94.2% | Added |
| Wellington Management Group LLP | 68,358 | $1.16M | 0.00% | +68,358 | New |
| D. E. Shaw & Co., Inc. | 61,621 | $1.05M | 0.00% | +12,702+26.0% | Added |
| Schonfeld Strategic Advisors LLC | 60,074 | $1.02M | 0.01% | −80,926−57.4% | Reduced |
| UBS Oconnor LLC | 59,352 | $1.01M | 0.03% | +5,000+9.2% | Added |
| American Century Companies Inc | 57,178 | $974.3K | 0.00% | +15,725+37.9% | Added |
| Cubist Systematic Strategies, LLC | 55,888 | $952.3K | 0.01% | −1,038−1.8% | Reduced |
| Invesco Ltd. | 47,407 | $807.8K | 0.00% | +36,784+346.3% | Added |
| Marshall Wace, LLP | 47,044 | $801.6K | 0.00% | +13,670+41.0% | Added |
| Rhumbline Advisers | 46,702 | $795.8K | 0.00% | +972+2.1% | Added |
| Swiss National Bank | 46,300 | $789.0K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 45,755 | $779.7K | 0.00% | +2,853+6.7% | Added |
| Martingale Asset Management L P | 42,529 | $724.7K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 40,192 | $684.9K | 0.00% | −45,032−52.8% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 36,401 | $620.3K | 0.00% | +36,401 | New |
| Susquehanna International Group, LLP | 34,615 | $589.8K | 0.00% | +14,651+73.4% | Added |
| Alliancebernstein L.P. | 33,200 | $565.7K | 0.00% | −10,180−23.5% | Reduced |
| STRS Ohio | 31,900 | $543.0K | 0.00% | +31,900 | New |
| Birchview Capital, LP | 25,114 | $427.9K | 0.35% | 00.0% | Unchanged |
| Nebula Research & Development LLC | 24,653 | $420.1K | 0.09% | +24,653 | New |
| California State Teachers Retirement System | 23,752 | $404.7K | 0.00% | −1,449−5.7% | Reduced |
| Price T Rowe Associates Inc | 22,842 | $390.0K | 0.00% | +820+3.7% | Added |
| Jump Financial, LLC | 21,690 | $369.6K | 0.01% | +21,690 | New |
| New York Life Investment Management LLC | 21,250 | $362.1K | 0.00% | −12,509−37.1% | Reduced |
| Jane Street Group, LLC | 21,004 | $357.9K | 0.00% | +7,202+52.2% | Added |
| Prudential Financial Inc | 20,225 | $344.6K | 0.00% | −19,900−49.6% | Reduced |
| State of Wisconsin Investment Board | 20,095 | $342.4K | 0.00% | +20,095 | New |
| Two Sigma Advisers, LP | 19,600 | $334.0K | 0.00% | −19,000−49.2% | Reduced |
| Legal & General Group Plc | 19,561 | $333.3K | 0.00% | +5,552+39.6% | Added |
| JPMorgan Chase & Co | 19,470 | $331.8K | 0.00% | −5,723−22.7% | Reduced |
| Cornercap Investment Counsel Inc | 18,579 | $316.6K | 0.05% | −139−0.7% | Reduced |
| Exchange Traded Concepts, LLC | 16,850 | $287.1K | 0.01% | +2,774+19.7% | Added |
| NEOS Investment Management LLC | 16,388 | $279.3K | 0.02% | +482+3.0% | Added |
| ExodusPoint Capital Management, LP | 16,347 | $279.0K | 0.00% | −13,290−44.8% | Reduced |
| Profund Advisors LLC | 15,263 | $260.1K | 0.01% | +15,263 | New |
| Commonwealth Equity Services, LLC | 14,704 | $251.0K | 0.00% | −6,255−29.8% | Reduced |
| MetLife Investment Management | 13,337 | $227.3K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 12,742 | $217.1K | 0.00% | −1,223,822−99.0% | Reduced |
| Harbor Capital Advisors, Inc. | 12,540 | $214.0K | 0.03% | −1,923−13.3% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 17,269 | $208.5K | 0.00% | +3,134+22.2% | Added |
| Manufacturers Life Insurance Company, The | 10,782 | $183.7K | 0.00% | +90+0.8% | Added |
| Virtus ETF Advisers LLC | 10,181 | $173.5K | 0.09% | −698−6.4% | Reduced |
| SG Americas Securities, LLC | 9,936 | $169.0K | 0.00% | −4,513−31.2% | Reduced |
| New York State Common Retirement Fund | 9,510 | $162.1K | 0.00% | +2,824+42.2% | Added |
| Wells Fargo & Company | 9,200 | $156.8K | 0.00% | +1,173+14.6% | Added |
| China Universal Asset Management Co., Ltd. | 8,996 | $153.3K | 0.02% | +4,042+81.6% | Added |
| Quest Partners LLC | 8,683 | $148.0K | 0.03% | −8,918−50.7% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,125 | $87.3K | 0.00% | −1,417−21.7% | Reduced |
| Ameritas Investment Partners, Inc. | 2,599 | $44.3K | 0.00% | +615+31.0% | Added |
| Parallel Advisors, LLC | 1,317 | $22.4K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,286 | $21.9K | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 1,273 | $21.7K | 0.00% | +1,273 | New |
| Amalgamated Bank | 896 | $15.0K | 0.00% | −1,274−58.7% | Reduced |
| GWM Advisors LLC | 723 | $12.3K | 0.00% | +723 | New |
| Royal Bank of Canada | 580 | $10.0K | 0.00% | −8,344−93.5% | Reduced |
| FMR LLC | 526 | $8.96K | 0.00% | +84+19.0% | Added |
| GAMMA Investing LLC | 496 | $8.45K | 0.00% | +84+20.4% | Added |
| Signaturefd, LLC | 451 | $7.68K | 0.00% | −407−47.4% | Reduced |
| Pacer Advisors, Inc. | 450 | $7.67K | 0.00% | +450 | New |
| US Bancorp | 428 | $7.29K | 0.00% | −76−15.1% | Reduced |
| Tower Research Capital LLC (TRC) | 325 | $5.54K | 0.00% | −9,909−96.8% | Reduced |
| Quadrant Capital Group LLC | 306 | $5.21K | 0.00% | +65+27.0% | Added |